At the news
? NEUTRALIMPACT 3/10 144 filed Aug 7, 2026 at 11:04 ET
Director Robert Chess filed a Form 144 notice to sell 18,417 shares of Twist Bioscience common stock, valued at approximately $2.04 million, pursuant to a 10b5-1 plan adopted on May 8, 2026. The sale is tied to a stock option exercise and represents a routine, pre-planned transaction by a director.
- Director Robert Chess intends to sell 18,417 shares of TWST common stock.
- Estimated market value of the proposed sale is $2,042,261.13.
- Sale is related to a stock option exercise on August 7, 2026.
- The 10b5-1 trading plan was adopted on May 8, 2026.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access